<!DOCTYPE html>
<html>
    <head>
        <title>Deep In Motion : Risk management</title>
        <link rel="stylesheet" href="styles/site.css" type="text/css" />
        <META http-equiv="Content-Type" content="text/html; charset=UTF-8">
    </head>

    <body class="theme-default aui-theme-default">
        <div id="page">
            <div id="main" class="aui-page-panel">
                <div id="main-header">
                    <div id="breadcrumb-section">
                        <ol id="breadcrumbs">
                            <li class="first">
                                <span><a href="index.html">Deep In Motion</a></span>
                            </li>
                                                    <li>
                                <span><a href="Deep-In-Motion-Home_401868245.html">Deep In Motion Home</a></span>
                            </li>
                                                    <li>
                                <span><a href="Index-of-tables_403308818.html">Index of tables</a></span>
                            </li>
                                                </ol>
                    </div>
                    <h1 id="title-heading" class="pagetitle">
                                                <span id="title-text">
                            Deep In Motion : Risk management
                        </span>
                    </h1>
                </div>

                <div id="content" class="view">
                    <div class="page-metadata">
                        
        
    
    
        
    
        
        
            Created by <span class='author'> Pål Haugen</span>, last updated on 18.08.2025
    
                        </div>
                    <div id="main-content" class="wiki-content group">
                    <p>Do not apply for prototypes, there is no QA team in the research project</p><div class="table-wrap"><table class="wrapped confluenceTable"><tbody class=""><tr class=""><td class="confluenceTd"><p>ID</p></td><td class="confluenceTd"><p><strong>Requirements</strong></p></td><td class="confluenceTd"><p><strong>Comments</strong></p></td><td class="confluenceTd"><p><strong>Regulatory references</strong></p></td></tr><tr class=""><td class="confluenceTd"><p><strong>21.1</strong></p></td><td class="confluenceTd"><p>The manufacturer has evaluated the risks that arise if the inputs do not meet the specified requirements<a class="external-link" href="https://github.com/johner-institut/ai-guideline/blob/master/Guideline-AI-Medical-Devices_EN.md#user-content-fn-C.2.a.2-b6daf829538eb59c530c6a09d03d7ff9" rel="nofollow"><sup>5</sup></a>.</p></td><td class="confluenceTd"><br/></td><td class="confluenceTd"><p>ISO 14971:2019, 5.4, IEC 62304, 7.1, DIN SPEC 2, IEC 82304 4.1.c)</p></td></tr><tr class=""><td class="confluenceTd"><p><strong>21.2</strong></p></td><td class="confluenceTd"><p>The manufacturer has derived the quantitative quality criteria based on the state of the art.</p></td><td class="confluenceTd"><p>The manufacturer shall be able to name the quality criteria for alternative technologies and procedures and to argue if the medical device is not superior to the alternatives with respect to the quality criteria <a class="external-link" href="https://github.com/johner-institut/ai-guideline/blob/master/Guideline-AI-Medical-Devices_EN.md#user-content-fn-C.5.d.1-b6daf829538eb59c530c6a09d03d7ff9" rel="nofollow"><sup>31</sup></a>.</p></td><td class="confluenceTd"><br/></td></tr><tr class=""><td class="confluenceTd"><p><strong>21.3</strong></p></td><td class="confluenceTd"><p>The manufacturer has defined the gold standard and justified its choice, which will be used to verify the quality criteria.</p></td><td class="confluenceTd"><br/></td><td class="confluenceTd"><p>XAVIER University &quot;Building Explainability and Trust for AI in Healthcare&quot;, FDA proposed regulatory framework for modifications to AI/ML based SaMD: &quot;reference standard&quot;</p></td></tr><tr class=""><td class="confluenceTd"><p><strong>21.4</strong></p></td><td class="confluenceTd"><p>The manufacturer has identified, evaluated, and managed risks that arise when outputs do not meet the specified quality criteria.</p></td><td class="confluenceTd"><p>In this analysis, the manufacturer also considers the specific properties of the selected model as well as the confidence intervals of the output values determined during testing.</p></td><td class="confluenceTd"><p>ISO 14971:2019, 5.3, IEC 62304, 7.1, IEC 82304, 4.1.c), XAVIER University &quot;Building Explainability and Trust for AI in Healthcare&quot;, FDA guidance on software validation, 5.2.2</p></td></tr><tr class=""><td class="confluenceTd"><p><strong>21.5</strong></p></td><td class="confluenceTd"><p>The manufacturer has evaluated the consequences if the system provides socially unacceptable outputs (e.g. discriminatory).</p></td><td class="confluenceTd"><p>These &quot;consequences&quot; are not necessarily risks in the sense of ISO 14971.</p></td><td class="confluenceTd"><p>Ethics guidelines for trustworthy AI</p></td></tr><tr class=""><td class="confluenceTd"><p><strong>21.6</strong></p></td><td class="confluenceTd"><p>The manufacturer has identified, evaluated and managed the risks if the system is not available.</p></td><td class="confluenceTd"><br/></td><td class="confluenceTd"><br/></td></tr><tr class=""><td class="confluenceTd"><p><strong>21.7</strong></p></td><td class="confluenceTd"><p>The manufacturer has identified, evaluated and managed the risks arising from software errors.</p></td><td class="confluenceTd"><p>This includes errors in SOUP as well as in the software used for &quot;pre-processing&quot; the data and for training the model.</p></td><td class="confluenceTd"><br/></td></tr><tr class=""><td class="confluenceTd"><p><strong>21.8</strong></p></td><td class="confluenceTd"><p>The manufacturer has identified, evaluated and managed the risks arising from the specific choice of model architecture.</p></td><td class="confluenceTd"><p>In doing so, manufacturers should also analyze whether the models have been optimized to the right specifications.</p></td><td class="confluenceTd"><p>ISO 14971:2019</p></td></tr><tr class=""><td class="confluenceTd"><p><strong>21.9</strong></p></td><td class="confluenceTd"><p>The manufacturer has identified, evaluated, and managed the risks posed by the specific choice of target platform.</p></td><td class="confluenceTd"><p>For example, the target platform might not provide the required computing power or might cause the software to crash.</p></td><td class="confluenceTd"><br/></td></tr><tr class=""><td class="confluenceTd"><p><strong>21.10</strong></p></td><td class="confluenceTd"><p>The manufacturer has identified, evaluated and managed the risks arising from the selection of training, validation and test data.</p></td><td class="confluenceTd"><p>This concerns both the sources of these data (such as patients, institutions) and the division of these data into training, validation and test data. For example, manufacturers should check that there is no overfitting or bias of the data.</p></td><td class="confluenceTd"><br/></td></tr><tr class=""><td class="confluenceTd"><p><strong>21.11</strong></p></td><td class="confluenceTd"><p>The manufacturer has identified, evaluated and managed the risks of outputs (predictions, classifications, etc.) being correct only by chance.</p></td><td class="confluenceTd"><p>Interpretability allows manufacturers to demonstrate why an ML-model has made a specific decision.</p></td><td class="confluenceTd"><br/></td></tr><tr class=""><td class="confluenceTd"><p><strong>21.12</strong></p></td><td class="confluenceTd"><p>The manufacturer has identified the risks posed by the fact that the predictions themselves change the predicted outcomes.</p></td><td class="confluenceTd"><p>In this phenomenon, the model changes from observer to actor [^C.5.d.2]. It is called &quot;performative prediction.&quot; Producers should investigate the possible effects on people or systems and describe them e.g. with a DAC (&quot;directed acyclic graph&quot;), observe a possible &quot;distribution shift&quot; and, if necessary, an unaffected control group, and take action if necessary such as choosing a different model or re-training the existing model.</p></td><td class="confluenceTd"><br/></td></tr><tr class=""><td class="confluenceTd"><p><strong>21.13</strong></p></td><td class="confluenceTd"><p>If the manufacturer uses self-tests, he has explained which of the specified quality criteria are checked with them and which risks are thereby controlled.</p></td><td class="confluenceTd"><br/></td><td class="confluenceTd"><br/></td></tr><tr class=""><td class="confluenceTd"><p><strong>21.14</strong></p></td><td class="confluenceTd"><p>The manufacturer has identified, evaluated and managed the risks from usage errors.</p></td><td class="confluenceTd"><p>These risks should also take into account that users do not recognize or misunderstand the explanation of the outputs (&quot;Explainability&quot;).</p></td><td class="confluenceTd"><p>IEC 62366-1, 5.3f, FDA HFE guidance, FDA guidance on software validation, 5.2.3</p></td></tr><tr class=""><td class="confluenceTd"><p><strong>21.15</strong></p></td><td class="confluenceTd"><p>The manufacturer has identified, evaluated and controlled the other risks mentioned in chapter C.1.d).</p></td><td class="confluenceTd"><br/></td><td class="confluenceTd"><br/></td></tr></tbody></table></div>
                    </div>

                                        
                                                      
                </div>             </div> 
            <div id="footer" role="contentinfo">
                <section class="footer-body">
                    <p>Document generated by Confluence on 19.08.2025 10:34 CEST</p>
                    <div id="footer-logo"><a href="https://www.atlassian.com/">Atlassian</a></div>
                </section>
            </div>
        </div>     </body>
</html>
